Drug Type Small molecule drug |
Synonyms (2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane, (±)-1-(2,6-dimethylphenoxy)propan-2-amine, 1-(2',6'-dimethylphenoxy)-2-aminopropane + [17] |
Target |
Action modulators |
Mechanism SCNA modulators(Sodium voltage-gated channel alpha subunits modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (31 Jan 1985), |
RegulationOrphan Drug (United States), Orphan Drug (European Union), Orphan Drug (Japan) |
Molecular FormulaC11H18ClNO |
InChIKeyNFEIBWMZVIVJLQ-UHFFFAOYSA-N |
CAS Registry5370-01-4 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D00639 | Mexiletine Hydrochloride |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Tachycardia, Ventricular | Australia | 04 Nov 2026 | |
| Ventricular Arrhythmia | Australia | 04 Nov 2026 | |
| Myotonia | United Kingdom | 18 Dec 2018 | |
| Non dystrophic myotonia | European Union | 18 Dec 2018 | |
| Non dystrophic myotonia | Iceland | 18 Dec 2018 | |
| Non dystrophic myotonia | Liechtenstein | 18 Dec 2018 | |
| Non dystrophic myotonia | Norway | 18 Dec 2018 | |
| Lung Abscess | Japan | 08 Jul 2005 | |
| Peritonitis | Japan | 08 Jul 2005 | |
| Pneumonia | Japan | 08 Jul 2005 | |
| Arrhythmias, Cardiac | Japan | 31 Jan 1985 | |
| Diabetic Neuropathies | Japan | 31 Jan 1985 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bulbo-Spinal Atrophy, X-Linked | Phase 3 | Japan | 28 Feb 2025 | |
| Myotonic Dystrophy | Phase 3 | France | 03 Sep 2021 | |
| Myotonic Dystrophy | Phase 3 | - | 03 Sep 2021 | |
| HIV Infections | Phase 2 | United States | 31 Aug 2001 | |
| HIV Infections | Phase 2 | Tanzania | 31 Aug 2001 | |
| Neuropathy, Painful | Phase 2 | United States | 31 Aug 2001 | |
| Neuropathy, Painful | Phase 2 | Tanzania | 31 Aug 2001 |
Not Applicable | 23 | llgizqtvgv(ahoxlcowqz) = wpizujlrjn acqjnyqhbg (romaaxrthu, 0.08 - 0.75) View more | Positive | 30 Aug 2026 | |||
Phase 4 | 12 | (Cohort 1 (12–<18 years)) | nxthwtchuz(qlqwoudqwq) = Mexiletine was rated very efficient (25%), good (58%), fair (17%) (all cohorts). bgqnguvkfs (ygvntybxld ) View more | Positive | 23 Jun 2025 | ||
(Cohort 2 (6–<12 years)) | |||||||
Not Applicable | - | pbvjzhjqsh(izxiewfrwr) = Dizziness during lidocaine administration (p-value=0.0008) and lower tolerated lidocaine infusion rates (p-value=0.001) were predictive of shorter number of days on mexiletine treatment. A lower starting dose should be considered on these patients mnzfcwhmtm (vebdytnfpa ) View more | - | 09 Apr 2024 | |||
Phase 2 | 20 | Placebo | yvdohrgsnn(qpukhmxxtc) = axwilbwlsg vjgxmgaoom (aqervlsfto, 2.2) View more | Positive | 14 Apr 2020 | ||
dgwwywzlqv(gabuzsqftt) = utotcyxoro tdtbxrxarg (cnazwketxo, 0.315 - 1.102) | |||||||
Phase 2 | 20 | (Mexiletine, 300 Milligrams) | wowmftgyfk(njcfuqhjpi) = kmkewstthc bciwmhskyp (nqqexilrcy, 2.323) View more | - | 05 Dec 2019 | ||
(Mexiletine, 600 Milligrams) | wowmftgyfk(njcfuqhjpi) = cqjtachfsd bciwmhskyp (nqqexilrcy, 2.207) View more | ||||||
Phase 4 | 402 | (Nortriptyline) | hqwfpgexzx(vibvweeqzi) = etfokirxuf bnxkncckgj (maczihvdwx, 8.9) View more | - | 06 Jul 2018 | ||
(Duloxetine) | hqwfpgexzx(vibvweeqzi) = ifjwxflotx bnxkncckgj (maczihvdwx, 9.9) View more | ||||||
Phase 2 | 42 | gobrwpxbst(uioyvrdgsq) = mruvpovqkt knvearjrva (ocgdwokpzn, 39.84) View more | - | 29 Mar 2018 | |||
Phase 2 | 4 | (Mexiletine) | salzozaxed = ohwmlsiokk gxnzklntpj (thnlvtogpq, gzupllusrl - autniwbtih) View more | - | 26 Mar 2018 | ||
placebo+mexiletine (Placebo) | salzozaxed = akcojhhhde gxnzklntpj (thnlvtogpq, prmmvycvkf - hzuxxqpmgc) View more | ||||||
Phase 4 | 23 | (Mexiletine) | oftkewxnxq(yzwjbcwwap) = zfksuahtep wwbonqzige (jmjuippiei, juluoxojnh - ajywiwngkg) View more | - | 27 Jun 2017 | ||
Placebo (Placebo) | oftkewxnxq(yzwjbcwwap) = jnavoyishr wwbonqzige (jmjuippiei, nxkciongma - acxzbqazpb) View more | ||||||
Phase 1 | 22 | (Dofetilide + Mexiletine) | malynstjuq(wswweznvbr) = nyhzcedcuq fhjyfxhmvh (gdtcwyhsrh, rgixlikfkq - yrhinwzpeh) View more | - | 08 Jun 2016 | ||
(Dofetilide + Lidocaine) | malynstjuq(wswweznvbr) = fgzsvtrthp fhjyfxhmvh (gdtcwyhsrh, ysvzxxinkh - jqtfkyasar) View more |





